Searchable abstracts of presentations at key conferences in endocrinology

ea0040p22 | (1) | ESEBEC2016

Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a sigle centre experience

Fabiana Pani , Mario Scartozzi , Francesco Atzori , Germana Baghino , Francesco Boi , Luciana Tanca , Teresa Ionta Maria , Stefano Mariotti

Background: The development of thyroid dysfunction is a frequent side effect associated to sunitinib therapy but scanty data are available on thyroid function on long-term sunitinib-treated patients.Objective: Prospective evaluation of 28 patients suffering from mRCC treated with sunitinib, enrolled between September 2013 and October 2015. 28 patients (24 men and 3 women (median age 57.7, range 51–77)) with comparable tumor staging, normal thyroid f...